Feedback / Questions
naloxone intranasal - Amphastar
http://www.globenewswire.com/news-release/2020/02/27/1991704/0/en/Amphastar-Pharmaceuticals-Receives-FDA-Approval-for-Supplement-to-its-Abbreviated-New-Drug-Application-for-Sodium-Bicarbonate-Injection-USP-8-4-50mEq-50mL.html
Feb 27, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next